These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Delayed Methotrexate Clearance Despite Carboxypeptidase-G2 (Glucarpidase) Administration in 2 Patients With Toxic Methotrexate Levels. Wyatt KD; Cooper J; Scott K; Broomall E; Altaf S; Hogan MC; Rodriguez V; Khan S J Pediatr Hematol Oncol; 2018 Mar; 40(2):152-155. PubMed ID: 29240024 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of glucarpidase (carboxypeptidase g2) in patients with acute kidney injury after high-dose methotrexate therapy. Widemann BC; Schwartz S; Jayaprakash N; Christensen R; Pui CH; Chauhan N; Daugherty C; King TR; Rush JE; Howard SC Pharmacotherapy; 2014 May; 34(5):427-39. PubMed ID: 24132809 [TBL] [Abstract][Full Text] [Related]
8. Severe acute toxicity associated with high-dose methotrexate (MTX) therapy: use of therapeutic drug monitoring and test-dose to guide carboxypeptidase G2 rescue and MTX continuation. Estève MA; Devictor-Pierre B; Galy G; André N; Coze C; Lacarelle B; Bernard JL; Monjanel-Mouterde S Eur J Clin Pharmacol; 2007 Jan; 63(1):39-42. PubMed ID: 17115148 [No Abstract] [Full Text] [Related]
9. Early recognition of renal toxicity of high-dose methotrexate therapy: a case report. Nowicki TS; Bjornard K; Kudlowitz D; Sandoval C; Jayabose S J Pediatr Hematol Oncol; 2008 Dec; 30(12):950-2. PubMed ID: 19131789 [TBL] [Abstract][Full Text] [Related]
10. Comparable efficacy with varying dosages of glucarpidase in pediatric oncology patients. Scott JR; Zhou Y; Cheng C; Ward DA; Swanson HD; Molinelli AR; Stewart CF; Navid F; Jeha S; Relling MV; Crews KR Pediatr Blood Cancer; 2015 Sep; 62(9):1518-22. PubMed ID: 25631103 [TBL] [Abstract][Full Text] [Related]
11. Clearance of methotrexate by means of hemofiltration in a patient with osteosarcoma. Escobosa Sánchez OM; Herrero Hernández A; Ortega Acosta MJ; Camacho Alonso J; Milano Manso G; Acha García T Clin Transl Oncol; 2006 May; 8(5):379-80. PubMed ID: 16760016 [No Abstract] [Full Text] [Related]
12. Carboxypeptidase-G2 rescue in a patient with high dose methotrexate-induced nephrotoxicity. Widemann BC; Hetherington ML; Murphy RF; Balis FM; Adamson PC Cancer; 1995 Aug; 76(3):521-6. PubMed ID: 8625136 [TBL] [Abstract][Full Text] [Related]
13. Successful rescue by oral cholestyramine of a patient with methotrexate nephrotoxicity: nonrenal excretion of serum methotrexate. Shinozaki T; Watanabe H; Tomidokoro R; Yamamoto K; Horiuchi R; Takagishi K Med Pediatr Oncol; 2000 Mar; 34(3):226-8. PubMed ID: 10696135 [No Abstract] [Full Text] [Related]
14. High-dose methotrexate-induced nephrotoxicity in patients with osteosarcoma. Widemann BC; Balis FM; Kempf-Bielack B; Bielack S; Pratt CB; Ferrari S; Bacci G; Craft AW; Adamson PC Cancer; 2004 May; 100(10):2222-32. PubMed ID: 15139068 [TBL] [Abstract][Full Text] [Related]
15. [Carboxypeptidase-G2-rescue in a woman with methotrexate-induced renal failure]. von Poblozki A; Dempke W; Schmoll HJ Med Klin (Munich); 2000 Aug; 95(8):457-60. PubMed ID: 10985069 [TBL] [Abstract][Full Text] [Related]
16. Using a lower dose of glucarpidase to reduce plasma levels of methotrexate. Widemann BC Clin Adv Hematol Oncol; 2013 May; 11(5):324-5. PubMed ID: 23880720 [No Abstract] [Full Text] [Related]